This is a preview of subscription content, log in via an institution to check access.
Reference
Minarik J, et al. Single agent daratumumab in advanced multiple myeloma: Specific healthcare program in the Czech Republic. Blood 130 (Suppl. 1): 5414, Dec 2017 [abstract] - Czech Republic
Rights and permissions
About this article
Cite this article
Daratumumab. Reactions Weekly 1695, 145 (2018). https://doi.org/10.1007/s40278-018-43972-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43972-8